Companies Attending
- Adaptive Sensory Technology
- Adverum Biotechnologies
- Aerie Pharmaceuticals
- Aerpio Therapeutics
- Albert Einstein College of Medicine and Montefiore
- Alcon
- Alimera Sciences
- Allegro Ophthalmics
- Allergan
- Apellis Pharmaceuticals
- Aptitude Medical Systems
- Aquilo Partners
- AsclepiX Therapeutics
- Associated Retina Specialist
- ASRS
- Astellas Pharma
- Auckland Eye Limited
- Bausch + Lomb
- Baylor College of Medicine
- Beaver Visitec International
- Beth Israel Deaconess Medical Center
- BioComm Network
- BioTime
- Boehringer Ingelheim Pharma
- Bryn Mawr Communications
- Burns McClellan
- Byers Eye Institute at Stanford
- California Retina Consultants
- Cambridge Consultants
- Carl Zeiss Meditec
- Cell Care Therapeutics
- Center for Retinal and Macular Diseases
- Charles Retina Institute
- Clarus Funds
- Clearside Biomedical
- Cydan
- DigiSight Technologies
- Drusolv Therapeutics
- Duke Eye Center
- Esteve
- Ethis Communications
- Evolve Medical Education
- Evolve Therapeutics
- ExSight Ventures
- Eyedaptic
- Foresite Capital
- ForSight Labs
- Fortress Biotech
- Gemini Therapeutics
- Genentech
- Gensight Biologics
- Glaucoma Technologies
- Graybug Vision
- Hatteras Venture Partners
- Haug Partners
- Heidelberg Engineering
- Hemera Biosciences
- Homology Medicines
- Illinois Retina Associates
- Indiana University School of Medicine
- InterWest Partners
- isonic Medical
- Istanbul Bilim University
- JPA Health Communications
- Kodiak Sciences
- Lagunita Biosciences
- Laidlaw
- Lexitas Pharma Services
- Lifecore Biomedical
- Long Island Vitreo Retinal
- LSU Health-Shreveport
- Merck
- Mimetogen Pharmaceuticals
- Miracles In Sight
- Mitotech
- Multi Radiance Medical
- NEA
- NeuMedics
- Nightstar
- Notal Vision
- Novartis
- Ocular Therapeutix
- OCULUS Surgical
- Ocunexus Therapeutics
- Ohr Pharmaceutical
- Omar Consulting Group
- ONL Therapeutics
- Ophthalmic Consultants of Boston
- Ophthotech
- Opthea Limited
- Optimal Acuity
- Ora
- Oxular
- Oyster Point Pharmaceuticals
- Pamdeca
- Patterson Thuente IP
- PentaVision
- PharmaQuest Associates
- Piper Jaffray
- ProFarma
- Promedica International
- pSivida
- RA Capital Management
- Regeneron
- REGENXBIO
- Retina Specialist
- Retinal Consultants of Arizona
- Retina-Vitreous Associated Medical Group
- Santen
- Santen Pharmaceuticals Ltd.
- SciFluor Life Sciences
- Scotia Vision
- SeeCare Technologies
- Shire
- Stealth BioTherapeutics
- Stein Eye Institute, UCLA
- Stephens
- Tennessee Retina
- The Fundingsland Group
- The Magnum Group
- The Ohio State University
- The Ritedose Corporation
- ThromboGenics NV
- TPG Capital
- Translatum Medicus inc
- Trial Runners
- TrueVision Systems
- Tufts Medical Center
- UCL and Imperial College London, Western Eye Hospital London
- University of Michigan
- University of Southern California
- University of Southern California & Los Angeles County – USC Medical Center
- USC Roski Eye Institute, Keck Medicine of USC
- Valley Retina Research
- Vestrum Health
- Vision Ophthalmic Development International
- VisionCare
- Vitreous Retina Macula Consultants of New York
- Weill Cornell Medical College
- West Coast Retina
- Yale University School of Medicine